复杂血管腔内动脉瘤修复中完全无碘对比剂方案
本研究报道6例慢性肾脏病3至5期合并胸腹主动脉瘤患者,在接受开窗或分支血管腔内动脉瘤修复(F/BEVAR)时采用从围术期至随访的完全无碘对比剂方案,术中仅用二氧化碳作为对比剂,术前及随访用双功能超声和近平扫CT评估;作者认为该方案在慢性肾脏病3至5期患者中可行且安全,未来需更大样本和更长随访。
要点
- 围术期无动脉瘤或手术相关并发症,6个月时瘤囊稳定且无内漏。
- 血清肌酐和估算肾小球滤过率在围术期及随访期间与术前相似。
核心结论
- 作者认为,完全无碘对比剂方案在慢性肾脏病3至5期合并胸腹主动脉瘤患者中行复杂血管腔内手术具有可行性和安全性。
- 作者认为,该方案可能避免肾功能进一步恶化,从而避免患者进入血液透析。
- 作者指出,未来需要更大样本和更长随访以获得更准确的数据。
研究设计与样本
- 单中心连续6例慢性肾脏病(3至5期)合并胸腹主动脉瘤患者,接受开窗或分支血管腔内动脉瘤修复(F/BEVAR),从围术期至随访采用完全无碘对比剂方案。
- 术前采用双功能超声和近平扫CT评估,并使用专用3D软件进行重建规划。
- 所有手术均以二氧化碳作为对比剂;随访时每位患者在1个月时接受近平扫CT,之后接受双功能超声评估。
主要发现
- 围术期无动脉瘤或手术相关并发症,无与使用二氧化碳相关的并发症。
- 6个月时,每例瘤囊稳定,未发现内漏。
- 围术期和随访期间血清肌酐和估算肾小球滤过率与术前相似。
临床怎么用
- 作者认为,该完全无碘对比剂方案可用于慢性肾脏病3至5期合并胸腹主动脉瘤患者的复杂血管腔内手术。
- 作者指出,未来需要更大样本和更长随访以获得更准确的数据。
局限性
- 样本量为6例。
- 作者指出未来需要更大样本和更长随访以获得更准确的数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Contrast-induced nephropathy is still a big issue related to using iodine contrast medium in patients with renal impairment undergoing complex endovascular aneurysm repair such as fenestrated or branched endovascular aneurysm repair (F/BEVAR). Although the use of carbon dioxide being well investigated in literature for standard EVAR, there are a few evidence about its use in F/BEVAR. The potential damage to kidneys is not only related to the procedure alone but also to the need to perform computed tomography angiography in the preoperative and postoperative period. With the aim to reduce the damage to renal function in patients with preexisting renal impairment, we report our experience of a total iodine contrast-free protocol in 6 patients with chronic kidney disease (stages from 3 to 5) who require a complex endovascular aneurysm repair due to an aneurysmatic disease of the thoracoabdominal aorta. MATERIALS AND METHODS: Six consecutive patients with chronic kidney disease underwent F/BEVAR at our institution following a total iodine contrast-free protocol, from perioperative period to follow-up. These patients were preoperatively evaluated with duplex ultrasounds and plain-computed tomography scan to perform proper reconstruction with dedicated 3D software. All the procedures were carried on with CO2 as contrast medium. During follow-up, every patient underwent plain-computed tomography scan at 1 month and then duplex ultrasound evaluations. RESULTS: Technical success was achieved in all cases. There were no aneurysm or procedure-related complications related to the use of CO2 in the perioperative period. At 6 months, in each case, the sac was stable and no endoleak were found. Serum creatinine and estimated glomerular filtration rate values were similar to preoperative ones both in the perioperative period and during follow-up. CONCLUSIONS: The total iodine contrast-free protocol showed its feasibility and safety to carry on complex endovascular procedures in patients affected by chronic kidney disease from stages 3 to 5 and concomitant aneurysmatic disease of the thoracoabdominal aorta. This protocol could also avoid further deteriorations of renal function that could lead those patients to hemodialysis. A large cohort of patient and an extended follow-up are required in the future to achieve more accurate data.Clinical ImpactThis study aims to evaluate an iodine-contrast-free protocol for patients with chronic kidney disease undergoing complex endovascular aortic repair, such as FEVAR or BEVAR. The use of this protocol may help preserve renal function and prevent further deterioration in patients at high risk for acute kidney injury or hemodialysis. Although the literature describes the role of CO2 as a non-nephrotoxic contrast agent, there are no reported experiences involving both preoperative and postoperative evaluation without the use of iodine-based contrast media.
引用
- Falso R, Speziali S, Di Domenico R, et al. Total Iodine Contrast-Free Protocol in Complex Endovascular Aneurysm Repair. J Endovasc Ther. 2025. PMID: 40448569. doi:10.1177/15266028251344793
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。